• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
4
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

A new mechanism of antimalarial drug resistance regulated at the epigenetic level

Mira Martínez, S.

2018

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Mira Martínez, S. (2018). A new mechanism of antimalarial drug resistance regulated at the epigenetic level.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

(2)

LIST OF ABBREVIATIONS

5-ALA 5-aminolevulinic acid

ACT Artemisinin-based combination therapy ART Artemisinin

AQ Amodiaquine

AZI Azithromycin BS Blasticidine S BSD Blasticidine S

CLAG Cytoadherence link asexual gene

CQ Chloroquine

DHODH Dihydroorotate dehydrogenase DHPS Dihydropteroate synthase EPCR Endothelial protein C receptor FOSMI Fosmidomycin

G6PD Glucose-6-phosphate dehydrogenase

gDNA Genomic DNA

GNI Gross National Income HbC Hemoglibne C

HbS Hemoglibne S

HP1 Heterochromatin protein 1 HVR Hypervariable region

ICAM1 Intercellular adhesion molecule 1 IPT Intermittent preventive treatment

IPTi Intermittent preventive treatment in infancy

IPTp Intermittent preventive treatment in pregnant women

IPT-SP Intermittent preventive treatment with sulfadoxine-pyrimethamine IRB Institutional Review Board

ISGlobal Barcelona Institute for Global Health ITM Institute of Tropical Medicne, Antwerp K13 PF3D7_1343700 kelch propeller domain LAMP Loop-mediated isothermal amplification LEUP Leupeptine

LM Light mycroscopy

(3)

LUM Lumefantrine

LysoPC Lysophosphatidylcholine

malERA Malaria eradication research agenda MDA Mass drug administriation

MDG Millennium Development Goals MDR-TB Mmultidrug-resistance tuberculosis MMV Medicines for Malaria Venture MOI Multiplicity of infection

MQ Mefloquine

NAT Nucleic acid tests ncRNA Non-conding RNA

NGS Next-generation sequencing NIH National Institutes of Health NO Nitric oxide

NPP New Permeation pathways

NtCR N-terminal paralogue-specific conserved region PCR Long polymerase chain reaction

PfCRT P. falciparum CQ resistance transporter

PfEMP1 P. falciparum erythrocyte membrane protein-1 PfHRP2 P. falciparum histidine-rich protein 2

PfMDR1 P. falciparum multidrug resistance transporter PfPI3K P. falciparum phosphatidylinositol-3-kinase PI3P PI3-phosphate

PPIX Protoporphyrin IX

PSAC Plasmodial Surface Anion Channel

PYR Pyrimethamine

qPCR Quantitative-PCR RBC Red blood cell

RDT Rapid diagnostic tests RSA Ring-stage survival assay RT-PCR Real Time - PCR

SDX Sulfadoxine

SMC Seasonal malaria chemoprevention SNP Single nucleotide polymorphisms SP Sulfadoxine-pyrimethamine

(4)

T3 Albitiazolium

TF Transcription factor WHO World Health Organization

Referenties

GERELATEERDE DOCUMENTEN

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of